Skip to main content

Closed

DRIO: DarioHealth Corp. Stock Analysis | finqOS

Healthcare · Medical - Diagnostics & Research

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+32.9% / yr

Operating margin-251.9%

ROIC-56.6%

Financially safe

Stretched

Debt / equity0.51×

Interest coverage-11.9×

Current ratio3.04×

Valuation

Unrated

P/E ratio2.2×

DarioHealth Corp.

DRIONASDAQ Capital Market·USD·Closed

DarioHealth Corp.

DRIONASDAQ·USD·Closed

$7.27

+0.97%

$7.27

+$0.07 (0.97%)

52W Range

12thpctl

Volume

0.58×avg

Mkt Cap

53.16MUSD

P/E

2.2TTM

Div Yield

–ann

52W Range

12thpctl

Volume

0.58×avg

Market Cap

53.16MUSD

P/E Ratio

2.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings